Further research examining the mechanisms of HS1 involvement in tumor invasion, metastasis, and malignancy, including studies involving chemotherapeutic agents, will provide new insights that may significantly impact the development of novel therapeutic strategies for primary ovarian carcinomas and their metastasis. This evidence concerns the gene HCLS1 and neoplasm.